A case control study of lung cancer in truck drivers was conducted. The cohort consisted of 996 cases of lung cancer occurring in members of the Teamsters Union who had filed claims for pension benefits and who died in 1982 and 1983. The comparisons consisted of 1085 union members who died from causes other than lung cancer, bladder cancer, and motor vehicle accidents during the same period. The next of kin were interviewed to obtain information on work history and potential confounders such as smoking, dietary habits, and asbestos (1332214) exposure. Odds ratios (ORs) for lung cancer were computed for type of job in the trucking industry, miles driven, whether the truck had a diesel engine, and similar factors. For subjects employed after 1959, the approximate time that diesel engines were introduced into the trucking industry, the risk of lung cancer increased with increasing duration of employment for short and long haul drivers. When no cutoff date was used the risk of lung cancer was not related to length of employment. When 1964 was used as the cutoff date, the lung cancer risk for long haul truck drivers with 13 plus years driving experience was significantly increased, OR 1.64. The risk was elevated for drivers who drove primarily diesel powered trucks. Truck mechanics revealed no increased risk for lung cancer that varied with duration of employment. There were no significant interactions between Lung cancer risk, exposure, smoking, or asbestos exposure. The authors conclude that positive trends in lung cancer risk have been established for persons employed as long haul truck drivers after 1959 and 1964 and for truck drivers who drove mostly diesel trucks. The study is limited, however, because of the lack of data on exposure to diesel fumes, possible job misclassification, and lack of sufficient latency to observe a lung cancer excess.
N. Kyle Steenland, PhD, Industrywide Studies Branch, Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health, Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, OH 45226
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.